Utilization of Optical Coherence Tomography in the Evaluation of Cherry Hemangiomas

Adam S. Aldahan, Stephanie Mlacker, Vidhi V. Shah, Lucy L. Chen, Keyvan Nouri, James M Grichnik

Research output: Contribution to journalArticle

Abstract

Cherry hemangiomas are common vascular proliferative lesions that can be concerning from a cosmetic perspective. Laser therapy is often used to eradicate cherry hemangiomas, but some lesions require multiple treatments or do not resolve at all. The suboptimal response to laser treatment may be due to limitations in penetration depth by vascular lasers such as the pulsed dye laser. Optical coherence tomography is a low-energy, light-based imaging device that can evaluate the depth and extent of vascular lesions such as cherry hemangiomas by allowing visualization of tissue structure and blood vessel architecture, which cannot be appreciated by clinical or dermatoscopic examination alone. We present optical coherence tomography images of a cherry hemangioma to demonstrate the precision and resolution of this imaging modality. Optical coherence tomography provides valuable information that has the potential to predict response to laser therapy without unnecessary attempts. Future prospective studies will determine its value for this purpose.

J Drugs Dermatol. 2016;15(6):713-714.

Original languageEnglish (US)
Pages (from-to)713-714
Number of pages2
JournalJournal of drugs in dermatology : JDD
Volume15
Issue number6
StatePublished - Jun 1 2016

Fingerprint

Optical Coherence Tomography
Hemangioma
Blood Vessels
Laser Therapy
Lasers
Dye Lasers
Cosmetics
Prospective Studies
Light
Equipment and Supplies
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)
  • Dermatology

Cite this

Aldahan, A. S., Mlacker, S., Shah, V. V., Chen, L. L., Nouri, K., & Grichnik, J. M. (2016). Utilization of Optical Coherence Tomography in the Evaluation of Cherry Hemangiomas. Journal of drugs in dermatology : JDD, 15(6), 713-714.

Utilization of Optical Coherence Tomography in the Evaluation of Cherry Hemangiomas. / Aldahan, Adam S.; Mlacker, Stephanie; Shah, Vidhi V.; Chen, Lucy L.; Nouri, Keyvan; Grichnik, James M.

In: Journal of drugs in dermatology : JDD, Vol. 15, No. 6, 01.06.2016, p. 713-714.

Research output: Contribution to journalArticle

Aldahan, AS, Mlacker, S, Shah, VV, Chen, LL, Nouri, K & Grichnik, JM 2016, 'Utilization of Optical Coherence Tomography in the Evaluation of Cherry Hemangiomas', Journal of drugs in dermatology : JDD, vol. 15, no. 6, pp. 713-714.
Aldahan, Adam S. ; Mlacker, Stephanie ; Shah, Vidhi V. ; Chen, Lucy L. ; Nouri, Keyvan ; Grichnik, James M. / Utilization of Optical Coherence Tomography in the Evaluation of Cherry Hemangiomas. In: Journal of drugs in dermatology : JDD. 2016 ; Vol. 15, No. 6. pp. 713-714.
@article{401ef193cf654bbe8fb8120f061777a5,
title = "Utilization of Optical Coherence Tomography in the Evaluation of Cherry Hemangiomas",
abstract = "Cherry hemangiomas are common vascular proliferative lesions that can be concerning from a cosmetic perspective. Laser therapy is often used to eradicate cherry hemangiomas, but some lesions require multiple treatments or do not resolve at all. The suboptimal response to laser treatment may be due to limitations in penetration depth by vascular lasers such as the pulsed dye laser. Optical coherence tomography is a low-energy, light-based imaging device that can evaluate the depth and extent of vascular lesions such as cherry hemangiomas by allowing visualization of tissue structure and blood vessel architecture, which cannot be appreciated by clinical or dermatoscopic examination alone. We present optical coherence tomography images of a cherry hemangioma to demonstrate the precision and resolution of this imaging modality. Optical coherence tomography provides valuable information that has the potential to predict response to laser therapy without unnecessary attempts. Future prospective studies will determine its value for this purpose. J Drugs Dermatol. 2016;15(6):713-714.",
author = "Aldahan, {Adam S.} and Stephanie Mlacker and Shah, {Vidhi V.} and Chen, {Lucy L.} and Keyvan Nouri and Grichnik, {James M}",
year = "2016",
month = "6",
day = "1",
language = "English (US)",
volume = "15",
pages = "713--714",
journal = "Journal of Drugs in Dermatology",
issn = "1545-9616",
publisher = "Journal of Drugs in Dermatology",
number = "6",

}

TY - JOUR

T1 - Utilization of Optical Coherence Tomography in the Evaluation of Cherry Hemangiomas

AU - Aldahan, Adam S.

AU - Mlacker, Stephanie

AU - Shah, Vidhi V.

AU - Chen, Lucy L.

AU - Nouri, Keyvan

AU - Grichnik, James M

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Cherry hemangiomas are common vascular proliferative lesions that can be concerning from a cosmetic perspective. Laser therapy is often used to eradicate cherry hemangiomas, but some lesions require multiple treatments or do not resolve at all. The suboptimal response to laser treatment may be due to limitations in penetration depth by vascular lasers such as the pulsed dye laser. Optical coherence tomography is a low-energy, light-based imaging device that can evaluate the depth and extent of vascular lesions such as cherry hemangiomas by allowing visualization of tissue structure and blood vessel architecture, which cannot be appreciated by clinical or dermatoscopic examination alone. We present optical coherence tomography images of a cherry hemangioma to demonstrate the precision and resolution of this imaging modality. Optical coherence tomography provides valuable information that has the potential to predict response to laser therapy without unnecessary attempts. Future prospective studies will determine its value for this purpose. J Drugs Dermatol. 2016;15(6):713-714.

AB - Cherry hemangiomas are common vascular proliferative lesions that can be concerning from a cosmetic perspective. Laser therapy is often used to eradicate cherry hemangiomas, but some lesions require multiple treatments or do not resolve at all. The suboptimal response to laser treatment may be due to limitations in penetration depth by vascular lasers such as the pulsed dye laser. Optical coherence tomography is a low-energy, light-based imaging device that can evaluate the depth and extent of vascular lesions such as cherry hemangiomas by allowing visualization of tissue structure and blood vessel architecture, which cannot be appreciated by clinical or dermatoscopic examination alone. We present optical coherence tomography images of a cherry hemangioma to demonstrate the precision and resolution of this imaging modality. Optical coherence tomography provides valuable information that has the potential to predict response to laser therapy without unnecessary attempts. Future prospective studies will determine its value for this purpose. J Drugs Dermatol. 2016;15(6):713-714.

UR - http://www.scopus.com/inward/record.url?scp=85021308317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021308317&partnerID=8YFLogxK

M3 - Article

C2 - 27272077

AN - SCOPUS:85021308317

VL - 15

SP - 713

EP - 714

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

SN - 1545-9616

IS - 6

ER -